KR100252452B1 - Stereoselective glycosylation process - Google Patents

Stereoselective glycosylation process Download PDF

Info

Publication number
KR100252452B1
KR100252452B1 KR1019930011312A KR930011312A KR100252452B1 KR 100252452 B1 KR100252452 B1 KR 100252452B1 KR 1019930011312 A KR1019930011312 A KR 1019930011312A KR 930011312 A KR930011312 A KR 930011312A KR 100252452 B1 KR100252452 B1 KR 100252452B1
Authority
KR
South Korea
Prior art keywords
deoxy
stereoselective
glycosylation process
difluoronucleosides
fluoronucleosides
Prior art date
Application number
KR1019930011312A
Other languages
English (en)
Other versions
KR940005658A (ko
Inventor
Chou Ta-Sen
Laurie Michelle Poteet
Patton Kjell Douglas
Cora Sue Grossman
Larry Wayne Hertel
Richard Elmer Holmes
David Jones Charles
Thomas Edward Madry
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27583678&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR100252452(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/902,312 external-priority patent/US5371210A/en
Priority claimed from US08/044,996 external-priority patent/US5821357A/en
Priority claimed from US08/044,345 external-priority patent/US5594124A/en
Priority claimed from US08/044,343 external-priority patent/US5401838A/en
Priority claimed from US08/044,312 external-priority patent/US5426183A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of KR940005658A publication Critical patent/KR940005658A/ko
Application granted granted Critical
Publication of KR100252452B1 publication Critical patent/KR100252452B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heat Sensitive Colour Forming Recording (AREA)
KR1019930011312A 1992-06-22 1993-06-21 Stereoselective glycosylation process KR100252452B1 (en)

Applications Claiming Priority (24)

Application Number Priority Date Filing Date Title
US902,313 1986-08-28
US90230292A 1992-06-22 1992-06-22
US90231392A 1992-06-22 1992-06-22
US90213592A 1992-06-22 1992-06-22
US90211292A 1992-06-22 1992-06-22
US90215092A 1992-06-22 1992-06-22
US902,135 1992-06-22
US902,312 1992-06-22
US902,112 1992-06-22
US902,302 1992-06-22
US902,150 1992-06-22
US07/902,312 US5371210A (en) 1992-06-22 1992-06-22 Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US4430993A 1993-04-07 1993-04-07
US4431593A 1993-04-07 1993-04-07
US08/044,996 US5821357A (en) 1992-06-22 1993-04-07 Stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoropurine and triazole nucleosides
US08/044,345 US5594124A (en) 1992-06-22 1993-04-07 Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
US044,309 1993-04-07
US044,343 1993-04-07
US08/044,343 US5401838A (en) 1992-06-22 1993-04-07 Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US08/044,312 US5426183A (en) 1992-06-22 1993-04-07 Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US044,312 1993-04-07
US044,996 1993-04-07
US044,345 1993-04-07
US044,315 1993-04-07

Publications (2)

Publication Number Publication Date
KR940005658A KR940005658A (ko) 1994-03-22
KR100252452B1 true KR100252452B1 (en) 2000-04-15

Family

ID=27583678

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930011312A KR100252452B1 (en) 1992-06-22 1993-06-21 Stereoselective glycosylation process

Country Status (20)

Country Link
EP (1) EP0577303B1 (ko)
JP (1) JP3313191B2 (ko)
KR (1) KR100252452B1 (ko)
AT (1) ATE158799T1 (ko)
BR (1) BR9302434A (ko)
CA (1) CA2098881C (ko)
CY (1) CY2067A (ko)
DE (1) DE69314239C5 (ko)
DK (1) DK0577303T3 (ko)
ES (1) ES2107624T3 (ko)
FI (1) FI108643B (ko)
GR (1) GR3025689T3 (ko)
HU (2) HUT64358A (ko)
IL (1) IL106071A (ko)
MX (1) MX9303707A (ko)
MY (1) MY115775A (ko)
NO (1) NO180235B3 (ko)
NZ (1) NZ247939A (ko)
PL (1) PL172348B1 (ko)
UA (1) UA41261C2 (ko)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5424416A (en) * 1993-08-25 1995-06-13 Eli Lilly And Company Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
US5559222A (en) * 1995-02-03 1996-09-24 Eli Lilly And Company Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
EP0779275A2 (en) 1995-12-13 1997-06-18 Eli Lilly And Company Alpha, Alpha - Difluoro-beta -hydroxy thiol esters and their synthesis
US6326507B1 (en) 1998-06-19 2001-12-04 Trustees Of Dartmouth College Therapeutic compounds and methods of use
WO2001060383A1 (en) 2000-02-18 2001-08-23 Southern Research Institute METHODS FOR SYNTHESIZING 2-CHLORO-9-(2-DEOXY-2-FLUORO-β-D-ARABINOFURANOSYL)-9H-PURIN-6-AMINE
US7435755B2 (en) 2000-11-28 2008-10-14 The Trustees Of Dartmouth College CDDO-compounds and combination therapies thereof
CA2449561A1 (en) * 2001-08-02 2003-02-13 Ilex Oncology, Inc. Process for preparing purine nucleosides
DK1465615T3 (da) 2002-01-15 2012-11-12 Dartmouth College Tricykliske bisenonderivater og fremgangsmåder til anvendelse heraf
US6884880B2 (en) * 2002-08-21 2005-04-26 Ash Stevens, Inc. Process for the preparation of 9-β-anomeric nucleoside analogs
WO2004041203A2 (en) 2002-11-04 2004-05-21 Xenoport, Inc. Gemcitabine prodrugs, pharmaceutical compositions and uses thereof
CN100384862C (zh) 2003-05-22 2008-04-30 独立行政法人科学技术振兴机构 α-选择性糖基化反应方法
WO2006070985A1 (en) * 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
MX2007010316A (es) * 2005-03-04 2008-02-19 Dabur Pharma Ltd Intermediario de 21-desoxi, 21,21-difluoro-d-ribofuranosil nucleosidos enriquecidos en (-anomero y proceso para prepararlo.
CA2689979C (en) * 2005-06-03 2013-04-23 Scinopharm Taiwan, Ltd. Process of making an alpha-anomer enriched 2 -deoxy- 2, 2 -difluoro-d-ribofuranosyl sulfonate and use thereof for making a beta nucleoside
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’，2’-二氟-胞苷合成的方法
US8921340B2 (en) 2006-11-17 2014-12-30 Trustees Of Dartmouth College Methods for using synthetic triterpenoids in the treatment of bone or cartilage diseases or conditions
CA2670099A1 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthesis and biological activities of new tricyclic-bis-enones (tbes)
WO2008064132A2 (en) 2006-11-17 2008-05-29 Trustees Of Dartmouth College Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
US20080262215A1 (en) * 2007-04-23 2008-10-23 Chemagis Ltd. Gemcitabine production process
CN100475832C (zh) 2007-05-31 2009-04-08 南京卡文迪许生物工程技术有限公司 一种新颖的高立体选择性合成吉西他滨工艺及中间体
EP2048151A1 (en) * 2007-10-10 2009-04-15 Cilag AG Method for producing nucleosides by direct glycosylation of the nucleoside base
EP2050757A1 (en) * 2007-10-10 2009-04-22 Cilag AG Method of producing 2' -deoxy-5-azacytidine (Decitabine)
SI2252283T1 (sl) 2008-01-11 2019-02-28 Reata Pharmaceuticals, Inc. Sintetični triterpenoidi in postopki uporabe pri zdravljenju bolezni
EA020467B1 (ru) 2008-04-18 2014-11-28 Ритэ Фамэсутикл, Инк. Соединения, обладающие противовоспалительной активностью, и фармацевтическая композиция на их основе
MX2010011437A (es) 2008-04-18 2010-12-20 Reata Pharmaceuticals Inc Moduladores antioxidantes de inflamacion: derivados del acido oleanolico con saturacion en el anillo c.
TW201004627A (en) 2008-04-18 2010-02-01 Reata Pharmaceuticals Inc Antioxidant inflammation modulators: novel derivatives of oleanolic acid
US8124799B2 (en) 2008-04-18 2012-02-28 Reata Pharmaceuticals, Inc. Antioxidant inflammation modulators: oleanolic acid derivatives with amino and other modifications at C-17
ME02751B (me) 2008-04-18 2018-01-20 Reata Pharmaceuticals Inc Antioksidansni modulatori upale: c-17 homologisani derivati oleanolinske kiseline
PT2833905T (pt) 2012-04-04 2018-08-06 Halozyme Inc Terapia de combinação com hialuronidase e um taxano dirigido a tumor
US8921419B2 (en) 2012-05-08 2014-12-30 Trustees Of Dartmouth College Triterpenoids and compositions containing the same
KR20150141968A (ko) * 2013-03-15 2015-12-21 에피제네틱스 파마 엘엘씨 플루오르화된 피리미딘 유사체 및 그의 사용 방법
CA3061621A1 (en) 2017-04-26 2018-11-01 Thomas I. Kalman Multitargeted nucleoside derivatives
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
ES2131152T3 (es) * 1987-08-28 1999-07-16 Lilly Co Eli Procedimiento para aislar selectivamente beta-2'-desoxi-2',2'-difluorocitidina o sus sales.
JPH0217199A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc ２’−デオキシ−β−アデノシンの製造方法
GB8816345D0 (en) * 1988-07-08 1988-08-10 Hoffmann La Roche Purine derivatives
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
EP0523110A1 (en) * 1990-04-04 1993-01-20 Nycomed Imaging As Nucleoside derivatives
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5256798A (en) * 1992-06-22 1993-10-26 Eli Lilly And Company Process for preparing alpha-anomer enriched 2-deoxy-2,2-difluoro-D-ribofuranosyl sulfonates

Also Published As

Publication number Publication date
NO932288A (no) 1993-12-23
MX9303707A (es) 1994-06-30
CA2098881C (en) 2005-06-07
HUT64358A (en) 1993-12-28
NZ247939A (en) 1996-02-27
BR9302434A (pt) 1994-02-16
FI108643B (fi) 2002-02-28
DK0577303T3 (da) 1997-10-27
KR940005658A (ko) 1994-03-22
CA2098881A1 (en) 1993-12-23
DE69314239T2 (de) 1998-02-19
GR3025689T3 (en) 1998-03-31
FI932869A (fi) 1993-12-23
JPH06157570A (ja) 1994-06-03
NO180235B (no) 1996-12-02
HU9301822D0 (en) 1993-09-28
IL106071A (en) 2006-08-20
PL299415A1 (en) 1994-03-07
NO180235C (no) 1997-03-12
CY2067A (en) 1993-06-21
JP3313191B2 (ja) 2002-08-12
ES2107624T3 (es) 1997-12-01
NO180235B3 (no) 2007-10-01
ATE158799T1 (de) 1997-10-15
HU0201196D0 (ko) 2002-06-29
FI932869A0 (fi) 1993-06-21
HU223837B1 (hu) 2005-02-28
IL106071A0 (en) 1993-10-20
MY115775A (en) 2003-09-30
NO932288D0 (no) 1993-06-21
DE69314239C5 (de) 2012-11-29
EP0577303B1 (en) 1997-10-01
UA41261C2 (uk) 2001-09-17
PL172348B1 (pl) 1997-09-30
DE69314239D1 (de) 1997-11-06
EP0577303A1 (en) 1994-01-05

Similar Documents

Publication Publication Date Title
KR100252452B1 (en) Stereoselective glycosylation process
TW254946B (ko)
CA2098874A1 (en) Stereoselective anion glycosylation process
HUT46334A (en) Process for producing adenosine-5'-carboxamide derivatives
EP0513067A4 (en) A pratical synthesis of 2'-deoxynucleosides and 2',3'-dideoxy-2',3'-didehydronucleosides
IL73521A0 (en) Preparation of intermediate compounds for the synthesis of nucleosides and certain such novel compounds
TW291480B (ko)
AU4421285A (en) Sialic acid derivatives, galactose derivatives and method for producing the same
GR3022477T3 (en) Stereoselective process for preparing beta-anomer enriched 2-deoxy-2, 2-difluoro-d-ribofuranosyl-3, 5-hydroxy protected-1-alkyl and aryl sulfonate intermediates.
ES8701192A1 (es) Procedimiento para la preparacion de nucleosidos
IT8621422A1 (it) Procedimento ed impianto per la produzione in continuo di fruttosio 1,6-difosfato mediante utilizzazione di lievito di birra immobilizzato
CA2054559A1 (en) Process of producing phosphatidylcholine derivatives
ZA854848B (en) Sialic acid derivatives,galactose derivatives and method for producing same
RU93046506A (ru) Способ получения нуклеозидов
IL102144A0 (en) Process for producing 2'-deoxy-2',2'-difluoro nucleosides
RU93046709A (ru) Способ получения нуклеозидов
AU568929B2 (en) 6-substituted prostaglandin e's and process for their preparation
Bansal et al. Kinetics of crystallization of ZrF sub 4-BaF sub 2-LaF sub 3 glass by differential scanning calorimetry--reply to comment on
IL86824A (en) Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin to 4'-deoxy-13(s)-dihydro-4'-iododoxorubicin
PH21759A (en) Fermentation process for producing 5'-inosinic acid

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
J206 Request for trial to confirm the scope of a patent right
J204 Request for invalidation trial [patent]
J501 Disposition of invalidation of trial
J301 Trial decision

Free format text: TRIAL DECISION FOR CONFIRMATION OF THE SCOPE OF RIGHT_DEFENSIVE REQUESTED 20060609

Effective date: 20061026

J204 Request for invalidation trial [patent]
J121 Written withdrawal of request for trial
J301 Trial decision

Free format text: TRIAL DECISION FOR INVALIDATION REQUESTED 20070824

Effective date: 20090831

J2X1 Appeal (before the patent court)

Free format text: INVALIDATION

J302 Written judgement (patent court)

Free format text: JUDGMENT (PATENT COURT) FOR INVALIDATION REQUESTED 20090930

Effective date: 20100702

J2X2 Appeal (before the supreme court)

Free format text: APPEAL BEFORE THE SUPREME COURT FOR INVALIDATION

EXTG Ip right invalidated
J303 Written judgement (supreme court)

Free format text: JUDGMENT (SUPREME COURT) FOR INVALIDATION REQUESTED 20110809

Effective date: 20111110